KKR is quietly building a medtech manufacturing powerhouse around Precipart
KKR is building Allyntra around Precipart to expand precision engineering and medical device manufacturing. See what the strategy means.
KKR is building Allyntra around Precipart to expand precision engineering and medical device manufacturing. See what the strategy means.
Medtronic’s Hugo filings could widen U.S. robotic surgery competition. Find out how the FDA review may challenge Intuitive Surgical.
DePuy Synthes wants to remove a robotics bottleneck. Its Gemtrack deal could change joint surgery navigation if regulators agree.
Pixee Medical's Knee+ NexSight receives CE mark. Analyse what AR guidance offers over robotics in total knee arthroplasty and what questions remain.
iotaMotion, Inc. has received U.S. Food and Drug Administration 510(k) clearance to expand the approved use of its iotaSOFT Robotic-Assisted Cochlear Implant Insertion System for children as young as four years old. This regulatory milestone makes the iotaSOFT system the first robotic-assisted cochlear insertion platform authorized for use in school-aged pediatric patients, expanding access to